Accession PRJCA016745
Title Single-cell profiling revealed tumor heterogeneity and microenvironment in surgically resectable esophageal squamous cell carcinoma with neoadjuvant chemoimmunotherapy
Relevance Medical
Data types Single cell sequencing
Organisms Homo sapiens
Description This study enrolled 22 patients diagnosed with stage II to IV ESCC, of whom 20 underwent neoadjuvant tislelizumab combined with chemotherapy before surgical removal and two were treated with camrelizumab plus chemotherapy before surgery. The dataset performed single-cell transcriptomic data of a total of 259,003 cells derived from 22 baseline and 24 post-NAT treatment samples of 22 stage II/III resectable ESCC patients.
Sample scope Multiisolate
Release date 2023-06-16
Publication
PubMed ID Article title Journal name DOI Year
38566201 Single-cell profiling of response to neoadjuvant chemo-immunotherapy in surgically resectable esophageal squamous cell carcinoma Genome Medicine 10.1186/s13073-024-01320-9 2024
Grants
Agency program Grant ID Grant title
Tangdu Hospital,Air Force Military Medical University, Xi'an,710038, P. R. China N/A
Submitter Qiang    Lu  (luqiang@fmmu.edu.cn)
Organization Air Force Medical University
Submission date 2023-04-28

Project Data

Resource name Description
BioSample (46)  show -